3,0
9 de jan. de 2024
Ex-funcionário(a), mais de 5 anos
Recomenda
Visão de mercado da empresa
Prós
Big company without good drugs in the pipeline
Contras
Seems like a different company without Ken Fraiser. Culture is very clickish IT does things the Merck way Not great pay Layoffs attitude about being a big pharma, but no greatness Layoffs on the hush so they dont get bad press EIC plan in Austin - didnt come through for those employees